MichaelStevenBraunMD

PubMed

• 177 citations
  Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
  Dan Rosmarin, Claire Palles, David N. Church, Enric Domingo, Angela M. Jones, Elaine C. Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder, George Nic...> ;Journal of Clinical Oncology. 2014 Apr 1
• 71 citations
  Balancing the efficacy and toxicity of chemotherapy in colorectal cancer
  Michael Braun, Matthew T. Seymour> ;Therapeutic Advances in Medical Oncology. 2011 Jan 1
• 100 citations
  Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
  Michael Braun, Susan D. Richman, L.C. Thompson, Catherine Daly, Angela M. Meade, Julian Adlard, James M. Allan, Mahesh K. B. Parmar, Philip Quirke, Matthew T. Seymour> ;Journal of Clinical Oncology. 2009 Nov 20
• 218 citations
  Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
  Michael Braun, Susan D. Richman, Philip Quirke, Catherine Daly, Julian Adlard, Faye Elliott, Jennifer H. Barrett, Peter Selby, Angela M. Meade, Richard Stephens, Mahes...> ;Journal of Clinical Oncology. 2008 Jun 1
• Detection of lymphatic vessel invasion in early breast cancer by the monoclonal antibody D2-40 (podoplanin).
  Braun M, Flucke U, Debald M, Pölcher M, Walgenbach-Bruenagel G, Walgenbach KJ, Büttner R, Kuhn W> ;J. Clin. Oncol.. 2008-05-20
• Incremental costs of chemotherapy-Pharmacoeconomic results from the prospective adjuvant AGO-WSG intergroup EC->DOC trial comparing an anthracycline-docetaxel sequence...
  Jacobs VR, Braun M, Harbeck N, Wagenpfeil S, Sattler D, Bernard R, Kuhn W, Ihbe-Heffinger A> ;J. Clin. Oncol.. 2008-05-20
• Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in-situ (DCIS) around invasive breast cancer.
  Schrading S, Gnatzy A, Wardelmann E, Braun M, Schild H, Kuhl CK> ;J. Clin. Oncol.. 2008-05-20
• 10 citations
  Molecular markers of chemotherapeutic response and toxicity in colorectal cancer
  Michael Braun, Philip Quirke, Matthew T. Seymour> ;Expert Review of Anticancer Therapy. 2007 Apr 1
• Prognostic value of thymidylate synthase (TS) expression on failure-free survival of fluorouracil-treated metastatic colorectal cancer patients.
  Richman S, Braun MS, Adlard JW, Daly C, Turner F, Barrett J, Meade A, Parmar M, Quirke P, Seymour MT> ;J. Clin. Oncol.. 2006-06-20
• Association of topoisomerase-1 (Topo1) with the efficacy of chemotherapy in a randomized trial for advanced colorectal cancer patients (FOCUS).
  Braun MS, Richman SD, Adlard JW, Daly C, Turner F, Barrett J, Parmar M, Selby P, Quirke P, Seymour MT> ;J. Clin. Oncol.. 2006-06-20
• Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer (FOCUS).
  Seymour MT, Braun MS, Richman SD, Daly C, Thompson LC, Meade A, Parmar M, Allan JM, Selby P, Quirke P> ;J. Clin. Oncol.. 2006-06-20
• Synovial sarcoma - Is adjuvant treatment of value? A retrospective review of adults and children treated at a single centre.
  Braun MS, Leahy M, Taylor RE, Merchant W, Lewis IJ> ;J. Clin. Oncol.. 2005-06-01
• A phase I study of chemo-radiotherapy using gemcitabine as a radiosensitiser in patients with metastases to the brain.
  Sgouros J, Upadhyay S, Braun M, Holmes M, Maraveyas A> ;J. Clin. Oncol.. 2004-07-15
• Weekly vinorelbine (VIN) vs weekly docetaxel (DOC) for metastatic breast cancer failing anthracyclines. Planned interim analysis of a randomized trial.
  Meier CR, Illiger HJ, Steder M, Braun M, Deertz H, Oeney HT> ;J. Clin. Oncol.. 2004-07-15
• 34 citations
  Phase I and Pharmacokinetic Study of Intravenous Irinotecan Plus Oral Ciclosporin in Patients With Fluorouracil-Refractory Metastatic Colon Cancer
  John D. Chester, Simon P. Joel, Susan L. Cheeseman, Geoffrey D. Hall, Michael Braun, Jackie Perry, Theresa Davis, Christopher J. Button, Matthew T. Seymour> ;Journal of Clinical Oncology. 2003 Mar 15
• Join now to see all